PAXIL Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Paxil, and what generic alternatives are available?

Paxil is a drug marketed by Apotex and is included in four NDAs.

The generic ingredient in PAXIL is paroxetine hydrochloride. There are thirty drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the paroxetine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Paxil

A generic version of PAXIL was approved as paroxetine hydrochloride by APOTEX on July 30^th, 2003.

Sign Up

Summary for PAXIL

US Patents:	0
Applicants:	1
NDAs:	4
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	68
Patent Applications:	3,738
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for PAXIL
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for PAXIL
What excipients (inactive ingredients) are in PAXIL?	PAXIL excipients list
DailyMed Link:	PAXIL at DailyMed

Drug patent expirations by year for PAXIL

Pharmacology for PAXIL

Drug Class	Serotonin Reuptake Inhibitor
Mechanism of Action	Serotonin Uptake Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for PAXIL

N06AB	Selective serotonin reuptake inhibitors
N06A	ANTIDEPRESSANTS
N06	PSYCHOANALEPTICS
N	Nervous system

US Patents and Regulatory Information for PAXIL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex	PAXIL	paroxetine hydrochloride	CAPSULE;ORAL	020885-001	Oct 9, 1998		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	TABLET;ORAL	020031-002	Dec 29, 1992	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	CAPSULE;ORAL	020885-004	Oct 9, 1998		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apotex	PAXIL CR	paroxetine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020936-002	Feb 16, 1999	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	TABLET;ORAL	020031-003	Dec 29, 1992	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	CAPSULE;ORAL	020885-002	Oct 9, 1998		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	CAPSULE;ORAL	020885-003	Oct 9, 1998		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PAXIL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Apotex	PAXIL	paroxetine hydrochloride	TABLET;ORAL	020031-002	Dec 29, 1992	⤷ Sign Up	⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	CAPSULE;ORAL	020885-004	Oct 9, 1998	⤷ Sign Up	⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	TABLET;ORAL	020031-001	Dec 29, 1992	⤷ Sign Up	⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	TABLET;ORAL	020031-001	Dec 29, 1992	⤷ Sign Up	⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	CAPSULE;ORAL	020885-003	Oct 9, 1998	⤷ Sign Up	⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	TABLET;ORAL	020031-001	Dec 29, 1992	⤷ Sign Up	⤷ Sign Up
Apotex	PAXIL	paroxetine hydrochloride	SUSPENSION;ORAL	020710-001	Jun 25, 1997	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PAXIL

See the table below for patents covering PAXIL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Czech Republic	285128	Orální kapalné prostředky obsahující resinát paroxetinu (ORAL LIQUID PHARMACEUTICAL PREPARATION CONTAINING COMPLEX OF PAROXETIN WITH AMERLITE IRP AND THE USE THEREOF)	⤷ Sign Up
New Zealand	280943	PAROXETINE TRANS-(-)-3-[(1,3-BENZODIOXOL-5-YL)METHOXY]-4-(4-FLUOROPHENYL) PIPERIDINE). HCL FREE OF BOUND SOLVENT (PARTICULARLY PROPAN-2-OL) AND VARIOUS FORMS THEREOF	⤷ Sign Up
Finland	112077		⤷ Sign Up
Spain	2129806		⤷ Sign Up
Ireland	S991108		⤷ Sign Up
Israel	140628		⤷ Sign Up
South Africa	9907477		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for PAXIL

Pharmacology for PAXIL

Anatomical Therapeutic Chemical (ATC) Classes for PAXIL

Make Better Decisions: Try a trial or see plans & pricing